BACKGROUND AND AIMS: It has been reported that matrix metalloproteinase (MMP) protein concentration and activity are upregulated in the failing human heart. However, there are few reports describing the role of elevated level of circulating MMPs in congestive heart failure (CHF) patients. This study examined whether circulating matrix metalloproteinases (MMPs) are also related to the pathogenesis of CHF. METHODS: We measured circulating levels of matrix metalloproteinase-2 (MMP-2) in 52 patients with CHF (left ventricular ejection fraction (LVEF) <50%). The patients were also subdivided into two groups according to NYHA functional class; mild CHF (class II, n=43) and severe CHF (class III, n=9). RESULTS: The serum level of MMP-2 and MMP-2/TIMP-2 ratio were significantly higher in CHF than in controls (P<0.01). Among patient groups, serum levels of MMP-2 were significantly higher in patients with severe CHF than in patients with mild CHF (P<0.01). Plasma levels of BNP had a significant positive correlation with circulating levels of MMP-2 (r=0.78; P<0.01) and MMP-2/TIMP-2 ratio (r=0.60; P<0.01). CONCLUSIONS: Our data showed that the circulating MMP-2 concentration was increased in CHF patients and that the levels were related to the plasma levels of BNP in CHF, suggesting that the elevated levels are related to developing heart failure syndrome.
BACKGROUND AND AIMS: It has been reported that matrix metalloproteinase (MMP) protein concentration and activity are upregulated in the failing human heart. However, there are few reports describing the role of elevated level of circulating MMPs in congestive heart failure (CHF) patients. This study examined whether circulating matrix metalloproteinases (MMPs) are also related to the pathogenesis of CHF. METHODS: We measured circulating levels of matrix metalloproteinase-2 (MMP-2) in 52 patients with CHF (left ventricular ejection fraction (LVEF) <50%). The patients were also subdivided into two groups according to NYHA functional class; mild CHF (class II, n=43) and severe CHF (class III, n=9). RESULTS: The serum level of MMP-2 and MMP-2/TIMP-2 ratio were significantly higher in CHF than in controls (P<0.01). Among patient groups, serum levels of MMP-2 were significantly higher in patients with severe CHF than in patients with mild CHF (P<0.01). Plasma levels of BNP had a significant positive correlation with circulating levels of MMP-2 (r=0.78; P<0.01) and MMP-2/TIMP-2 ratio (r=0.60; P<0.01). CONCLUSIONS: Our data showed that the circulating MMP-2 concentration was increased in CHFpatients and that the levels were related to the plasma levels of BNP in CHF, suggesting that the elevated levels are related to developing heart failure syndrome.
Authors: Tobias Täger; Clara Wiebalck; Hanna Fröhlich; Anna Corletto; Hugo A Katus; Lutz Frankenstein Journal: Clin Res Cardiol Date: 2017-08-04 Impact factor: 5.460
Authors: Vikas Bhalla; Vasiliki V Georgiopoulou; Ali A Azeem; Catherine N Marti; Robert T Cole; Sonjoy R Laskar; Christine De Staercke; W Craig Hooper; Andrew L Smith; Andreas P Kalogeropoulos; Javed Butler Journal: Int J Cardiol Date: 2011-07-01 Impact factor: 4.164
Authors: Lawrence S Lee; Ravi K Ghanta; Suyog A Mokashi; Otavio Coelho-Filho; Raymond Y Kwong; Michael Kwon; Jian Guan; Ronglih Liao; Frederick Y Chen Journal: J Thorac Cardiovasc Surg Date: 2012-06-12 Impact factor: 5.209
Authors: Hui-Zhong Zhou; Xiaokui Ma; Mary O Gray; Bo-qing Zhu; Anita P Nguyen; Anthony J Baker; Ursula Simonis; Gary Cecchini; David H Lovett; Joel S Karliner Journal: Biochem Biophys Res Commun Date: 2007-04-23 Impact factor: 3.575
Authors: Andrew T Yan; Raymond T Yan; Francis G Spinale; Rizwan Afzal; Himali R Gunasinghe; Robert E Stroud; Robert S McKelvie; Peter P Liu Journal: Eur J Heart Fail Date: 2008-01-29 Impact factor: 15.534
Authors: Hector R Mobine; Aaron B Baker; Libin Wang; Hiroko Wakimoto; Kurt C Jacobsen; Christine E Seidman; J G Seidman; Elazer R Edelman Journal: Circ Heart Fail Date: 2009-02-10 Impact factor: 8.790
Authors: David H Lovett; Rajeev Mahimkar; Robert L Raffai; Leslie Cape; Elena Maklashina; Gary Cecchini; Joel S Karliner Journal: PLoS One Date: 2012-04-03 Impact factor: 3.240